Genetic epidemiology of Charcot-Marie-Tooth in the general population

European Journal of Neurology

Volumn 18, Issue 1, 2011, Pages 39-48

  Braathen, G J ^a,b   Sand, J C ^a   Lobato, A ^a   Hoyer H ^b   Russell, M B ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b TELEMARK HOSPITAL   (Norway)

Author keywords

Charcot Marie Tooth; Epidemiology; Mutations; Neurophysiology

Indexed keywords

CONNEXIN 32; EARLY GROWTH RESPONSE FACTOR 2; MITOFUSIN 2; MYELIN PROTEIN; PERIPHERAL MYELIN PROTEIN 22;

ARTICLE; FAMILY STRESS; FEMALE; GENE MUTATION; GENETIC EPIDEMIOLOGY; HEALTH SURVEY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE CONDUCTION; NORWAY; NUCLEOTIDE SEQUENCE; POINT MUTATION; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL;

CHARCOT-MARIE-TOOTH DISEASE; CONNEXINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MITOCHONDRIAL PROTEINS; MUTATION; MYELIN P0 PROTEIN; MYELIN PROTEINS; NORWAY; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 78650079774     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03037.x     Document Type: Article

References (45)

1. Charcot JM, Marie P. Sur une form particulière d'atrophie musculaire progressive, souvant familiale, debutant par les pieds et les jambes, et atteignant plus tard les mains. Rev Méd (Paris) 1886; 6: 97-138.
2. Tooth HH. The Peroneal Type of Progressive Muscular Atrophy. London: H. K. Lewis, 1886.
3. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974; 6: 98-118.
4. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 1968; 18: 603-618.
5. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980; 103: 259-280.
6. Davis CJF, Bradley W, Madrid R. The peroneal muscular atrophy syndrome. Clinical, genetic, electrophysiological and nerve biopsy studies. J Genet Hum 1978; 274: 775-780.
7. Online Mendelian Inheritance in Man. (accessed 09/02/2010).
8. Szigeti K, Lupski JR. Charcot-Marie-Tooth disease. Eur J Hum Genet 2009; 17: 703-710.
9. Statistics Norway. (accessed 09/12/2009).
10. Aarskog NK, Vedeler CA. Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. Hum Genet 2000; 107: 494-498.
11. NCBI GenBank Overview. (accessed 31/01/2007).
12. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S eds. Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, NJ: Humana Press, 2000: 365-386 (accessed 31/01/2007).
13. den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet 2001; 109: 121-124.
14. Martyn CN, Hughes RAC. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997; 62: 310-318.
15. Holmberg BH, Holmgren G, Nelis E, van Broeckhoven C, Westerberg B. Charcot-Marie-Tooth disease in northern Sweden: pedigree analysis and the presence of the duplication in chromosome 17p11.2. J Med Genet 1994; 31: 435-441.
16. Silander K, Meretoja P, Juvonen V, et al. Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies. Hum Mutat 1998; 12: 59-68.
17. Choi BO, Lee MS, Shin SH, et al. Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients. Hum Mutat 2004; 24: 185-186.
18. Harding AE, Thomas PK. Hereditary distal spinal muscular atrophy. A report on 34 cases and a review of the literature. J Neurol Sci 1980; 45: 337-348.
19. Wise CA, Garcia CA, Davis SN, et al. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMTIA duplication. Am J Hum Genet 1993; 53: 853-863.
20. Boerkoel CF, Takashima H, Garcia CA, et al. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 2002; 51: 190-201.
21. Lucotte G, Berriche S, Bathelier C, et al. Molecular characterization of Charcot-Marie-Tooth patients in 15 pedigrees from France. Genet Couns 1995; 6: 355-360.
22. Kurihara S, Adachi Y, Wada K, Awaki E, Harada H, Nakashima K. An epidemiological genetic study of Charcot-Marie-Tooth disease in Western Japan. Neuroepidemiology 2002; 21: 246-250.
23. Yoshihara T, Yamamoto M, Doyu M, et al. Mutations in the peripheral myelin protein zero and connexin32 genes detected by non-isotopic RNase cleavage assay and their phenotypes in Japanese patients with Charcot-Marie-Tooth disease. Hum Mutat 2000; 16: 177-178.
24. Yoshihara T, Yamamoto M, Hattori N, et al. Identification of novel sequence variants in the neurofilament-light gene in a Japanese population: analysis of Charcot-Marie-Tooth disease patients and normal individuals. J Peripher Nerv Syst 2002; 7: 221-224.
25. Numakura C, Lin C, Ikegami T, Guldberg P, Hayasaka K. Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations. Hum Mutat 2002; 20: 392-398.
26. Mersiyanova IV, Ismailov SM, Polyakov AV, et al. Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 in Russian Charcot-Marie-Tooth neuropathy patients. Hum Mutat 2000; 15: 340-347.
27. Bort S, Martínez F, Palau F. Prevalence and parental origin of de novo 1.5-Mb duplication in Charcot-Marie-Tooth disease type 1A. Am J Hum Genet 1997; 60: 230-233.
28. Bort S, Nelis E, Timmerman V, et al. Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies. Hum Genet 1997; 99: 746-754.
29. Janssen EA, Kemp S, Hensels GW, et al. Connexin32 gene mutations in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum Genet 1997; 99: 501-505.
30. Choi JR, Lee WH, Sunwoo IN, Lee EK, Lee CH, Lim JB. Effectiveness of real-time quantitative PCR compare to repeat PCR for the diagnosis of Charcot-Marie-Tooth Type 1A and hereditary neuropathy with liability to pressure palsies. Yonsei Med J 2005; 46: 347-352.
31. Stangler Herodez S, Zagradisnik B, Erjavec Skerget A, Zagorac A, Kokalj Vokac N. Molecular diagnosis of PMP22 gene duplications and deletions: comparison of different methods. J Int Med Res 2009; 37: 1626-1631.
32. Combarros O, Calleja J, Polo JM, Berciano J. Prevalence of hereditary motor and sensory neuropathy in Cantabria. Acta Neurol Scand 1987; 75: 9-12.
33. Morocutti C, Colazza GB, Soldati G, et al. Charcot-Marie-Tooth disease in Molise, a central-southern region of Italy: an epidemiological study. Neuroepidemiology 2002; 21: 241-245.
34. Gu{Eth}mundsson B, Olafsson E, Jakobsson F, Lú{Eth}vígsson P. Prevalence of symptomatic Charcot-Marie-Tooth disease in Iceland: a study of a well-defined population. Neuroepidemiology 2010; 34: 13-17.
35. Blair IP, Nash J, Gordon MJ, Nicholson GA. Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: first report of a de novo duplication with a maternal origin. Am J Hum Genet 1996; 58: 472-476.
36. Berkson J. Limitations of the application of fourfold tables to hospital data. Biometrics Bull 1946; 2: 47-53.
37. Sackett DL. Bias in analytic research. J Chronic Dis 1979; 32: 51-63.
38. Verhoeven K, Claeys KG, Zuchner S, et al. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 2006; 129: 2093-2102.
39. Fairweather N, Bell C, Cochrane S, et al. Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease. Hum Mol Genet 1994; 3: 29-34.
40. Braathen GJ, Sand JC, Bukholm G, Russell MB. Two novel connexin32 mutations cause early onset X-linked Charcot-Marie-Tooth disease. BMC Neurol 2007; 7: 19.
41. Züchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004; 36: 449-451.
42. Braathen GJ, Sand JC, Lobato A, Hoyer H, Russell MB. MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families. BMC Med Genet 2010; 11: 48.
43. Haites NE, Nelis E, Van Broeckhoven C. 3rd workshop of the European CMT consortium: 54th ENMC international workshop on genotype/phenotype correlations in Charcot-Marie-Tooth type 1 and hereditary neuropathy with liability to pressure palsies, 28-30. November 1997, Naarden, The Netherlands. Neuromuscul Disord 1998; 8: 591-603.
44. Inherited Peripheral Neuropathies Mutation Database. (accessed 09/02/2010).
45. Szigeti K, Garcia CA, Lupski JR. Charcot-Marie-Tooth Disease and related hereditary polyneuropathies: molecular diagnostics determine aspects of medical management. Genet Med 2006; 8: 86-92.